Gesundheitswelt Chiemgau Valuation

Q: What is the Fair Price of JTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

JTH (€12.2) is trading below our estimate of [[fair value]] (€153.62)

Is JTH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of JTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: JTH (€12.2) is trading below our estimate of fair value (€153.62)

Significantly Below Fair Value: JTH is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for JTH?

Key metric: As JTH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for JTH. This is calculated by dividing JTH's market cap by their current earnings.
What is JTH's PE Ratio?
PE Ratio	6.8x
Earnings	€3.49m
Market Cap	€23.79m

JTH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.6x
Enterprise Value/EBITDA	5.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does JTH's PE Ratio compare to its peers?

The above table shows the PE ratio for JTH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	15.6x
EIF MedNation	1.7x	n/a	€4.2m
LIK LIMES Schlosskliniken	23.5x	n/a	€100.3m
M12 M1 Kliniken	18.6x	17.5%	€311.7m
RHK RHÖN-KLINIKUM	18.6x	7.5%	€836.7m
JTH Gesundheitswelt Chiemgau	6.8x	n/a	€23.8m

Price-To-Earnings vs Peers: JTH is good value based on its Price-To-Earnings Ratio (6.8x) compared to the peer average (15.6x).

Price to Earnings Ratio vs Industry

How does JTH's PE Ratio compare vs other companies in the European Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: JTH is good value based on its Price-To-Earnings Ratio (6.8x) compared to the European Healthcare industry average (18.2x).

Price to Earnings Ratio vs Fair Ratio

What is JTH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

JTH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	6.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate JTH's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ship Healthcare Holdings

JP¥196.5b

Engages in the medical, healthcare, welfare, and nursing care businesses worldwide.

5EZ

JP¥12.40

-3.1%

-4.6%

Sensus Healthcare

US$125.2m

A medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

5TX

US$7.25

16.0%

272.6%

CVS Health

US$66.9b

Provides health solutions in the United States.

CVS

US$53.25

2.4%

-14.7%